Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

The new compound may be a safer alternative to finasteride for prostate protection.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Baricitinib is effective as a treatment for severe hair loss.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

An elderly Chinese man lost all his hair after taking a new heart medication.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Removing the Crif1 gene in mouse skin disrupts skin balance and hair growth.

Baricitinib is effective for severe alopecia areata but has some side effects.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Finasteride helps female-pattern hair loss.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Abatacept may help some people with alopecia areata regrow hair.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.